- Filed
- Apr 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 16, 2025 | 46.86M sh |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $2.96B |
| Long Term Debt | Q1 2025 · Dec 29, 2024 | $2.65B |
| Short Term Debt | Q1 2025 · Mar 30, 2025 | $200K |
| Short Term Debt | Q1 2025 · Dec 29, 2024 | $300K |
| Cash And Equivalents | Q1 2025 · Mar 30, 2025 | $461.5M |
| Cash And Equivalents | Q1 2025 · Dec 29, 2024 | $649.8M |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $1.36B |
| Current Liabilities | Q1 2025 · Dec 29, 2024 | $1.26B |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $5.12B |
| Total Liabilities | Q1 2025 · Dec 29, 2024 | $4.65B |
| Current Assets | Q1 2025 · Mar 30, 2025 | $2.98B |
| Current Assets | Q1 2025 · Dec 29, 2024 | $2.94B |
| Total Assets | Q1 2025 · Mar 30, 2025 | $15.05B |
| Total Assets | Q1 2025 · Dec 29, 2024 | $14.2B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 48M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $15.9M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $291M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $9.33B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $9.22B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $3.72 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $3.77 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $219.7M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $76.5M |
| Net Income | Q1 2025 · Mar 31, 2024 | $178.5M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $234.3M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $770.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.35B |